294 related articles for article (PubMed ID: 12518224)
1. Expression of human papillomavirus type 6 L1 and L2 isolated in China and self assembly of virus-like particles by the products.
Wang M; Wang LL; Chen LF; Han YH; Zou YH; Si JY; Song GX
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Jan; 35(1):27-34. PubMed ID: 12518224
[TBL] [Abstract][Full Text] [Related]
2. Human papillomavirus type 16 capsid proteins produced from recombinant Semliki Forest virus assemble into virus-like particles.
Heino P; Dillner J; Schwartz S
Virology; 1995 Dec; 214(2):349-59. PubMed ID: 8553535
[TBL] [Abstract][Full Text] [Related]
3. Yeast coexpression of human papillomavirus types 6 and 16 capsid proteins.
Buonamassa DT; Greer CE; Capo S; Yen TS; Galeotti CL; Bensi G
Virology; 2002 Feb; 293(2):335-44. PubMed ID: 11886254
[TBL] [Abstract][Full Text] [Related]
4. Gene transfer using recombinant rabbit hemorrhagic disease virus capsids with genetically modified DNA encapsidation capacity by addition of packaging sequences from the L1 or L2 protein of human papillomavirus type 16.
El Mehdaoui S; Touzé A; Laurent S; Sizaret PY; Rasschaert D; Coursaget P
J Virol; 2000 Nov; 74(22):10332-40. PubMed ID: 11044077
[TBL] [Abstract][Full Text] [Related]
5. The L1 major capsid protein of human papillomavirus type 16 variants affects yield of virus-like particles produced in an insect cell expression system.
Touze A; El Mehdaoui S; Sizaret PY; Mougin C; Muñoz N; Coursaget P
J Clin Microbiol; 1998 Jul; 36(7):2046-51. PubMed ID: 9650960
[TBL] [Abstract][Full Text] [Related]
6. Broad Cross-Protection Is Induced in Preclinical Models by a Human Papillomavirus Vaccine Composed of L1/L2 Chimeric Virus-Like Particles.
Boxus M; Fochesato M; Miseur A; Mertens E; Dendouga N; Brendle S; Balogh KK; Christensen ND; Giannini SL
J Virol; 2016 Jul; 90(14):6314-25. PubMed ID: 27147749
[TBL] [Abstract][Full Text] [Related]
7. Encapsidating artificial human papillomavirus-16 mE7 protein in human papillomavirus-6b L1/L2 virus like particles.
Xu YF; Wang QY; Zhang HT; Han YH; Song GX; Xu XM
Chin Med J (Engl); 2007 Mar; 120(6):503-8. PubMed ID: 17439745
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and assembly of virus-like particles of human papillomaviruses type 6 and type 16 in fission yeast Schizosaccharomyces pombe.
Sasagawa T; Pushko P; Steers G; Gschmeissner SE; Hajibagheri MA; Finch J; Crawford L; Tommasino M
Virology; 1995 Jan; 206(1):126-35. PubMed ID: 7831768
[TBL] [Abstract][Full Text] [Related]
9. Chimeric human papillomavirus type 16 (HPV-16) L1 particles presenting the common neutralizing epitope for the L2 minor capsid protein of HPV-6 and HPV-16.
Varsani A; Williamson AL; de Villiers D; Becker I; Christensen ND; Rybicki EP
J Virol; 2003 Aug; 77(15):8386-93. PubMed ID: 12857908
[TBL] [Abstract][Full Text] [Related]
10. Efficient self-assembly of human papillomavirus type 16 L1 and L1-L2 into virus-like particles.
Kirnbauer R; Taub J; Greenstone H; Roden R; Dürst M; Gissmann L; Lowy DR; Schiller JT
J Virol; 1993 Dec; 67(12):6929-36. PubMed ID: 8230414
[TBL] [Abstract][Full Text] [Related]
11. [Sequence analysis of the late region of human papillomavirus type 6 genome].
Wang M; Zhang MC; Xu XM; Chen LF; Song GX
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Dec; 23(6):568-72. PubMed ID: 12901100
[TBL] [Abstract][Full Text] [Related]
12. Enhanced papillomavirus-like particle production in insect cells.
Senger T; Schädlich L; Gissmann L; Müller M
Virology; 2009 Jun; 388(2):344-53. PubMed ID: 19409593
[TBL] [Abstract][Full Text] [Related]
13. Type-specific and cross-reactive antibodies induced by human papillomavirus 31 L1/L2 virus-like particles.
Xu Y; Wang Q; Han Y; Song G; Xu X
J Med Microbiol; 2007 Jul; 56(Pt 7):907-913. PubMed ID: 17577054
[TBL] [Abstract][Full Text] [Related]
14. Self-assembly of human papillomavirus type 1 capsids by expression of the L1 protein alone or by coexpression of the L1 and L2 capsid proteins.
Hagensee ME; Yaegashi N; Galloway DA
J Virol; 1993 Jan; 67(1):315-22. PubMed ID: 8380079
[TBL] [Abstract][Full Text] [Related]
15. In vitro generation and type-specific neutralization of a human papillomavirus type 16 virion pseudotype.
Roden RB; Greenstone HL; Kirnbauer R; Booy FP; Jessie J; Lowy DR; Schiller JT
J Virol; 1996 Sep; 70(9):5875-83. PubMed ID: 8709207
[TBL] [Abstract][Full Text] [Related]
16. Expression of vaccinia recombinant HPV 16 L1 and L2 ORF proteins in epithelial cells is sufficient for assembly of HPV virion-like particles.
Zhou J; Sun XY; Stenzel DJ; Frazer IH
Virology; 1991 Nov; 185(1):251-7. PubMed ID: 1656586
[TBL] [Abstract][Full Text] [Related]
17. Production of human papillomavirus type 33 L1 major capsid protein and virus-like particles from Bacillus subtilis to develop a prophylactic vaccine against cervical cancer.
Baek JO; Seo JW; Kwon O; Park SM; Kim CH; Kim IH
Enzyme Microb Technol; 2012 Mar; 50(3):173-80. PubMed ID: 22305172
[TBL] [Abstract][Full Text] [Related]
18. L2, the minor capsid protein of papillomavirus.
Wang JW; Roden RB
Virology; 2013 Oct; 445(1-2):175-86. PubMed ID: 23689062
[TBL] [Abstract][Full Text] [Related]
19. Expression of human papillomavirus type 11 L1 protein in insect cells: in vivo and in vitro assembly of viruslike particles.
Rose RC; Bonnez W; Reichman RC; Garcea RL
J Virol; 1993 Apr; 67(4):1936-44. PubMed ID: 8383219
[TBL] [Abstract][Full Text] [Related]
20. Hybrid papillomavirus L1 molecules assemble into virus-like particles that reconstitute conformational epitopes and induce neutralizing antibodies to distinct HPV types.
Christensen ND; Cladel NM; Reed CA; Budgeon LR; Embers ME; Skulsky DM; McClements WL; Ludmerer SW; Jansen KU
Virology; 2001 Dec; 291(2):324-34. PubMed ID: 11878901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
